Analysis of circulating tumor DNA from atebimetinib-treated patients shows acquired MAPK pathway alterations are rare, supporting observed ...

Theriva Biologics Inc (NYSE American:TOVX) shares surged 73.6% Monday following the company’s announcement of new data from its VIRAGE Phase 2b clinical trial evaluating VCN-01 plus chemotherapy in ...

Translational study in metastatic triple-negative breast cancer (mTNBC) shows leronlimab-mediated CCR5 inhibition induces PD-L1 expression, ...

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

The 47th Annual Heart Rhythm Society (HRS) meeting kicks off Thursday in Chicago and online, attracting more than 10,000 ...

Theriva Biologics to present additional data from VIRAGE phase 2b trial of VCN-01 in metastatic pancreatic cancer at AACR 2026 meeting: Rockville, Maryland Monday, April 20, 2026, ...

Theriva Biologics (TOVX) stock surged 63% after Phase 2b trial data revealed VCN-01 plus chemo improved survival in ...

Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases April 20, 2026 8:30 AM ...

SLS and ATNM are heading into the AACR summit with fresh leukemia-focused data catalysts expected to refocus investor attention. ・Sellas will present preclinical AML data on SLS009, demonstrating ...

TROP2 and PTEN Biomarkers May Predict Patient Response to Reqorsa® Gene TherapyREQORSA Induced Apoptosis and Decreased Tumor Volume in ALK-EML4 Positive ...

Immunofoco today announced the presentation of new preclinical data for its in vivo BCMA-targeting CAR-T candidate, IMV102, at the AACR Annual Meeting 2026. The data demonstrate that IMV102 achieved ...

Theriva Biologics, Inc. TOVX shares are trading higher Monday after the company announced an upcoming poster presentation of ...